{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:41:20Z","timestamp":1791477680193,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Outstanding Youth Innovation Team Project in Natural Sciences","award":["2024KYYWF-TD01"],"award-info":[{"award-number":["2024KYYWF-TD01"]}]},{"name":"Research start-up funds for talent introduction of Harbin Sport University","award":["RC20-202105; RC20-202107"],"award-info":[{"award-number":["RC20-202105; RC20-202107"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45268-9","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T13:24:54Z","timestamp":1774099494000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apigenin combined with aerobic exercise alleviates oxidative stress and inflammation in high-fat diet-induced NAFLD mice by modulating the Keap1\/Nrf2\/ARE pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Nixi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangrui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"issue":"Suppl 3","key":"45268_CR1","first-page":"52","volume":"70","author":"P Angulo","year":"2005","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. Rev Gastroenterol. Mex Nov. 70 (Suppl 3), 52\u201356 (2005).","journal-title":"Rev Gastroenterol. Mex Nov"},{"issue":"3","key":"45268_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi, Z. M. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol Mar. 70 (3), 531\u2013544. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033 (2019).","journal-title":"J Hepatol Mar."},{"issue":"6","key":"45268_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol Dec. 79 (6), 1542\u20131556. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003 (2023).","journal-title":"J Hepatol Dec."},{"issue":"1","key":"45268_CR4","doi-asserted-by":"publisher","first-page":"2480250","DOI":"10.1080\/07853890.2025.2480250","volume":"57","author":"W Li","year":"2025","unstructured":"Li, W. et al. Lipid profile and non-alcoholic fatty liver disease detected by ultrasonography: is systemic inflammation a necessary mediator? Ann Med Dec. 57 (1), 2480250. https:\/\/doi.org\/10.1080\/07853890.2025.2480250 (2025).","journal-title":"Ann Med Dec."},{"issue":"5","key":"45268_CR5","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","volume":"169","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M. et al. Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis. Gastroenterology Oct. 169 (5), 1017\u20131032e2. https:\/\/doi.org\/10.1053\/j.gastro.2025.02.044 (2025).","journal-title":"Gastroenterology Oct."},{"issue":"Suppl 1","key":"45268_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/liv.13643","volume":"38","author":"AR Ara\u00fajo","year":"2018","unstructured":"Ara\u00fajo, A. R., Rosso, N., Bedogni, G., Tiribelli, C. & Bellentani, S. Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: What we need in the future. Liver Int Feb. 38 (Suppl 1), 47\u201351. https:\/\/doi.org\/10.1111\/liv.13643 (2018).","journal-title":"Liver Int Feb"},{"issue":"10","key":"45268_CR7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1055\/a-2266-1503","volume":"56","author":"M Li","year":"2024","unstructured":"Li, M. et al. The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases. Horm Metab. Res Oct. 56 (10), 683\u2013696. https:\/\/doi.org\/10.1055\/a-2266-1503 (2024).","journal-title":"Horm Metab. Res Oct."},{"key":"45268_CR8","doi-asserted-by":"publisher","first-page":"103385","DOI":"10.1016\/j.redox.2024.103385","volume":"77","author":"H Jian","year":"2024","unstructured":"Jian, H. et al. Branched-chain amino acids alleviate NAFLD via inhibiting de novo lipogenesis and activating fatty acid \u03b2-oxidation in laying hens. Redox Biol Nov. 77, 103385. https:\/\/doi.org\/10.1016\/j.redox.2024.103385 (2024).","journal-title":"Redox Biol Nov"},{"issue":"1","key":"45268_CR9","doi-asserted-by":"publisher","first-page":"2539448","DOI":"10.1080\/19490976.2025.2539448","volume":"17","author":"J Choi","year":"2025","unstructured":"Choi, J. et al. Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation. Gut Microbes Dec. 17 (1), 2539448. https:\/\/doi.org\/10.1080\/19490976.2025.2539448 (2025).","journal-title":"Gut Microbes Dec."},{"issue":"8","key":"45268_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3748\/wjg.v19.i8.1158","volume":"28","author":"M Basaranoglu","year":"2013","unstructured":"Basaranoglu, M., Basaranoglu, G. & Sent\u00fcrk, H. From fatty liver to fibrosis: a tale of second hit. World J. Gastroenterol Feb. 28 (8), 1158\u20131165. https:\/\/doi.org\/10.3748\/wjg.v19.i8.1158 (2013).","journal-title":"World J. Gastroenterol Feb"},{"issue":"8","key":"45268_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism Aug. 65 (8), 1038\u20131048. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012 (2016).","journal-title":"Metabolism Aug"},{"key":"45268_CR12","doi-asserted-by":"publisher","unstructured":"Roeb, E. & Geier, A. Apr. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. Z Gastroenterol. 57(4):508\u2013517. Nichtalkoholische Steatohepatitis (NASH) \u2013 aktuelle Behandlungsempfehlungen und zuk\u00fcnftige Entwicklungen. (2019). https:\/\/doi.org\/10.1055\/a-0784-8827","DOI":"10.1055\/a-0784-8827"},{"issue":"6","key":"45268_CR13","doi-asserted-by":"publisher","first-page":"e1438","DOI":"10.1016\/j.cgh.2021.06.029","volume":"20","author":"D Kim","year":"2022","unstructured":"Kim, D., Konyn, P., Cholankeril, G. & Ahmed, A. Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Clin Gastroenterol. Hepatol Jun. 20 (6), e1438\u2013e1455. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.029 (2022).","journal-title":"Clin Gastroenterol. Hepatol Jun"},{"issue":"7","key":"45268_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","volume":"19","author":"P Farzanegi","year":"2019","unstructured":"Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M. & Azarbayjani, M. A. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. Eur J. Sport Sci Aug. 19 (7), 994\u20131003. https:\/\/doi.org\/10.1080\/17461391.2019.1571114 (2019).","journal-title":"Eur J. Sport Sci Aug"},{"key":"45268_CR15","doi-asserted-by":"publisher","unstructured":"Neshat, S. Y., Quiroz, V. M., Wang, Y., Tamayo, S. & Doloff, J. C. Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions. Int J. Mol. Sci 24 (13). https:\/\/doi.org\/10.3390\/ijms22136777 (2021).","DOI":"10.3390\/ijms22136777"},{"key":"45268_CR16","doi-asserted-by":"publisher","unstructured":"Allameh, A., Niayesh-Mehr, R., Aliarab, A., Sebastiani, G. & Pantopoulos, K. Oxidative Stress in Liver Pathophysiology and Disease. Antioxidants (Basel) 22 (9). https:\/\/doi.org\/10.3390\/antiox12091653 (2023).","DOI":"10.3390\/antiox12091653"},{"issue":"10","key":"45268_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.31083\/j.fbl2810237","volume":"17","author":"IG Lee","year":"2023","unstructured":"Lee, I. G., Lee, J., Hong, S. H. & Seo, Y. J. Apigenin\u2019s Therapeutic Potential Against Viral Infection. Front Biosci. (Landmark Ed) 17 (10), 237. https:\/\/doi.org\/10.31083\/j.fbl2810237 (2023).","journal-title":"Front Biosci. (Landmark Ed) Oct."},{"key":"45268_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bcp.2019.05.027","volume":"166","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q., Cheng, K. W., Gong, J., Li, E. T. S. & Wang, M. Apigenin and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells. Biochem Pharmacol Aug. 166, 231\u2013241. https:\/\/doi.org\/10.1016\/j.bcp.2019.05.027 (2019).","journal-title":"Biochem Pharmacol Aug"},{"key":"45268_CR19","doi-asserted-by":"publisher","first-page":"2302896","DOI":"10.1155\/2017\/2302896","volume":"2017","author":"F Li","year":"2017","unstructured":"Li, F. et al. Apigenin Alleviates Endotoxin-Induced Myocardial Toxicity by Modulating Inflammation, Oxidative Stress, and Autophagy. Oxid. Med. Cell. Longev. 2017, 2302896. https:\/\/doi.org\/10.1155\/2017\/2302896 (2017).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"45268_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21873\/cgp.20146","volume":"16","author":"D Bauer","year":"2019","unstructured":"Bauer, D., Mazzio, E. & Soliman, K. F. A. Whole Transcriptomic Analysis of Apigenin on TNF\u03b1 Immuno-activated MDA-MB-231 Breast Cancer Cells. Cancer Genomics Proteomics Nov-Dec. 16 (6), 421\u2013431. https:\/\/doi.org\/10.21873\/cgp.20146 (2019).","journal-title":"Cancer Genomics Proteomics Nov-Dec"},{"key":"45268_CR21","doi-asserted-by":"publisher","unstructured":"Wang, B. et al. The Effects of Flavonoid Apigenin on Male Reproductive Health: Inhibition of Spermatogonial Proliferation through Downregulation of Prmt7\/Akt3 Pathway. Int J. Mol. Sci 11 (22). https:\/\/doi.org\/10.3390\/ijms222212209 (2021).","DOI":"10.3390\/ijms222212209"},{"issue":"1","key":"45268_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2016.08.023","volume":"66","author":"R Hashida","year":"2017","unstructured":"Hashida, R. et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol Jan. 66 (1), 142\u2013152. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.023 (2017).","journal-title":"J Hepatol Jan"},{"key":"45268_CR23","doi-asserted-by":"crossref","unstructured":"Fang C, Liu S, Yang W, et al. Exercise ameliorates lipid droplet metabolism disorder by the PLIN2-LIPA axis-mediated lipophagy in mouse model of non-alcoholic fatty liver disease. Biochim Biophys Acta Mol Basis Dis. 1870(3):167045. doi:10.1016\/j.bbadis.2024.167045 (2024).","DOI":"10.1016\/j.bbadis.2024.167045"},{"issue":"05","key":"45268_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.16386\/j.cjpccd.issn.1004-6194.2023.05.015","volume":"31","author":"\u738b\u838e\u838e","year":"2023","unstructured":"Mokhtari-Andani F, Talebi-Garakani E, Nasiri K, Akbari A. Exercise training and Silymarin consumption can ameliorate mitophagy signaling flux in hepatocytes of rats with dexamethasone-induced non-alcoholic fatty liver disease. Sci Rep. Oct 21 2025;15(1):36637. doi:10.1038\/s41598-025-20512-w.","journal-title":"\u4e2d\u56fd\u6162\u6027\u75c5\u9884\u9632\u4e0e\u63a7\u5236"},{"key":"45268_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jnutbio.2019.05.015","volume":"71","author":"Y Lv","year":"2019","unstructured":"Lv, Y. et al. Apigenin ameliorates HFD-induced NAFLD through regulation of the XO\/NLRP3 pathways. J Nutr. Biochem Sep. 71, 110\u2013121. https:\/\/doi.org\/10.1016\/j.jnutbio.2019.05.015 (2019).","journal-title":"J Nutr. Biochem Sep."},{"issue":"6","key":"45268_CR26","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00394-023-03179-9","volume":"62","author":"Y Bai","year":"2023","unstructured":"Bai, Y. et al. Aerobic exercise and vitamin E improve high-fat diet-induced NAFLD in rats by regulating the AMPK pathway and oxidative stress. Eur J. Nutr Sep. 62 (6), 2621\u20132632. https:\/\/doi.org\/10.1007\/s00394-023-03179-9 (2023).","journal-title":"Eur J. Nutr Sep."},{"key":"45268_CR27","doi-asserted-by":"publisher","unstructured":"Guo, X., Yin, X., Liu, Z. & Wang, J. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. Int J. Mol. Sci 7 (24). https:\/\/doi.org\/10.3390\/ijms232415489 (2022).","DOI":"10.3390\/ijms232415489"},{"issue":"7","key":"45268_CR28","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","volume":"63","author":"F Ameer","year":"2014","unstructured":"Ameer, F., Scandiuzzi, L., Hasnain, S., Kalbacher, H. & Zaidi, N. De novo lipogenesis in health and disease. Metabolism Jul. 63 (7), 895\u2013902. https:\/\/doi.org\/10.1016\/j.metabol.2014.04.003 (2014).","journal-title":"Metabolism Jul"},{"key":"45268_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"May 20","author":"Z Chen","year":"2020","unstructured":"Chen, Z., Tian, R., She, Z., Cai, J. & Li, H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radic Biol. Med. May 20, 152:116\u2013141. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.025 (2020).","journal-title":"Free Radic Biol. Med."},{"issue":"1","key":"45268_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche, K., Igoudjil, A., Pessayre, D. & Fromenty, B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion Feb. 6 (1), 1\u201328. https:\/\/doi.org\/10.1016\/j.mito.2005.10.004 (2006).","journal-title":"Mitochondrion Feb"},{"issue":"11","key":"45268_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","volume":"42","author":"J Lee","year":"2019","unstructured":"Lee, J., Park, J. S. & Roh, Y. S. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease. Arch Pharm. Res Nov. 42 (11), 935\u2013946. https:\/\/doi.org\/10.1007\/s12272-019-01178-1 (2019).","journal-title":"Arch Pharm. Res Nov"},{"key":"45268_CR32","doi-asserted-by":"publisher","first-page":"103159","DOI":"10.1016\/j.redox.2024.103159","volume":"72","author":"T Lv","year":"2024","unstructured":"Lv, T. et al. SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression. Redox Biol Jun. 72, 103159. https:\/\/doi.org\/10.1016\/j.redox.2024.103159 (2024).","journal-title":"Redox Biol Jun"},{"issue":"9","key":"45268_CR33","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1039\/d0fo02736g","volume":"11","author":"J Li","year":"2021","unstructured":"Li, J. et al. Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD. Food Funct May. 11 (9), 3898\u20133918. https:\/\/doi.org\/10.1039\/d0fo02736g (2021).","journal-title":"Food Funct May"},{"key":"45268_CR34","doi-asserted-by":"publisher","unstructured":"Weng, B., Zhang, X., Chu, X., Gong, X. & Cai, C. Nrf2\u2013Keap1\u2013ARE\u2013NQO1 signaling attenuates hyperoxia\u2013induced lung cell injury by inhibiting apoptosis. Mol Med. Rep 23 (3). https:\/\/doi.org\/10.3892\/mmr.2021.11860 (2021).","DOI":"10.3892\/mmr.2021.11860"},{"key":"45268_CR35","doi-asserted-by":"publisher","first-page":"154561","DOI":"10.1016\/j.phymed.2022.154561","volume":"109","author":"B Shen","year":"2023","unstructured":"Shen, B. et al. Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2. Phytomedicine Jan. 109, 154561. https:\/\/doi.org\/10.1016\/j.phymed.2022.154561 (2023).","journal-title":"Phytomedicine Jan"},{"issue":"20","key":"45268_CR36","doi-asserted-by":"publisher","first-page":"e2300763120","DOI":"10.1073\/pnas.2300763120","volume":"16","author":"Y Ko","year":"2023","unstructured":"Ko, Y. et al. S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling. Proc Natl. Acad. Sci. U S A May. 16 (20), e2300763120. https:\/\/doi.org\/10.1073\/pnas.2300763120 (2023).","journal-title":"Proc Natl. Acad. Sci. U S A May"},{"issue":"5","key":"45268_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza, I., Giambanco, I., Minelli, A. & Donato, R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim Biophys. Acta Mol. Cell. Res May. 1865 (5), 721\u2013733. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.02.010 (2018).","journal-title":"Biochim Biophys. Acta Mol. Cell. Res May"},{"issue":"8","key":"45268_CR38","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1128\/mcb.26.8.2887-2900.2006","volume":"26","author":"KI Tong","year":"2006","unstructured":"Tong, K. I. et al. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell. Biol Apr. 26 (8), 2887\u20132900. https:\/\/doi.org\/10.1128\/mcb.26.8.2887-2900.2006 (2006).","journal-title":"Mol Cell. Biol Apr"},{"issue":"4","key":"45268_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","volume":"34","author":"JD Hayes","year":"2009","unstructured":"Hayes, J. D. & McMahon, M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem. Sci Apr. 34 (4), 176\u2013188. https:\/\/doi.org\/10.1016\/j.tibs.2008.12.008 (2009).","journal-title":"Trends Biochem. Sci Apr"},{"issue":"1","key":"45268_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13046-023-02775-1","volume":"1","author":"T Xu","year":"2023","unstructured":"Xu, T. et al. TNFAIP2 confers cisplatin resistance in head and neck squamous cell carcinoma via KEAP1\/NRF2 signaling. J Exp. Clin. Cancer Res Aug. 1 (1), 190. https:\/\/doi.org\/10.1186\/s13046-023-02775-1 (2023).","journal-title":"J Exp. Clin. Cancer Res Aug"},{"issue":"6","key":"45268_CR41","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1074\/jbc.M411451200","volume":"11","author":"F Katsuoka","year":"2005","unstructured":"Katsuoka, F., Motohashi, H., Engel, J. D. & Yamamoto, M. Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J Biol. Chem Feb. 11 (6), 4483\u20134490. https:\/\/doi.org\/10.1074\/jbc.M411451200 (2005).","journal-title":"J Biol. Chem Feb"},{"issue":"10","key":"45268_CR42","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.bbamcr.2008.05.024","volume":"1783","author":"W Li","year":"2008","unstructured":"Li, W. et al. Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motif. Biochim Biophys. Acta Oct. 1783 (10), 1847\u20131856. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.05.024 (2008).","journal-title":"Biochim Biophys. Acta Oct."},{"issue":"1","key":"45268_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2022.08.022","volume":"78","author":"J Park","year":"2023","unstructured":"Park, J. et al. IL-6\/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease. J Hepatol Jan. 78 (1), 45\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.022 (2023).","journal-title":"J Hepatol Jan"},{"issue":"1","key":"45268_CR44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/tp.0000000000002480","volume":"103","author":"I Pierantonelli","year":"2019","unstructured":"Pierantonelli, I. & Svegliati-Baroni, G. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Transplantation Jan. 103 (1), e1\u2013e13. https:\/\/doi.org\/10.1097\/tp.0000000000002480 (2019).","journal-title":"Transplantation Jan"},{"key":"45268_CR45","doi-asserted-by":"publisher","unstructured":"Ma, Y., Lee, G., Heo, S. Y. & Roh, Y. S. Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease. Antioxidants (Basel) 30 (1). https:\/\/doi.org\/10.3390\/antiox11010091 (2021).","DOI":"10.3390\/antiox11010091"},{"issue":"2","key":"45268_CR46","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3892\/mmr.2016.5393","volume":"14","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-\u03baB in mice fed a high-fat diet. Mol Med. Rep Aug. 14 (2), 1323\u20131331. https:\/\/doi.org\/10.3892\/mmr.2016.5393 (2016).","journal-title":"Mol Med. Rep Aug"},{"issue":"02","key":"45268_CR47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14104\/j.cnki.1006-2076.2019.02.011","volume":"35","author":"\u90b5\u957f\u4e13","year":"2019","unstructured":"Zhang J, Yuan Y, Gao X, et al. Scopoletin ameliorates hyperlipidemia and hepatic steatosis via AMPK, Nrf2\/HO-1 and NF-\u03baB signaling pathways. Biochem Pharmacol. 231:116639. doi:10.1016\/j.bcp.2024.116639 (2025).","journal-title":"\u8010\u529b\u8bad\u7ec3\u7ea0\u6b63\u9ad8\u8102\u996e\u98df\u76f8\u5173\u7684\u975e\u9152\u7cbe\u6027\u8102\u80aa\u809d\u5927\u9f20\u809d\u810f\u7ebf\u7c92\u4f53\u529f\u80fd\u7d0a\u4e71\u63a2\u8ba8 \u5c71\u4e1c\u4f53\u80b2\u5b66\u9662\u5b66\u62a5"},{"key":"45268_CR48","doi-asserted-by":"publisher","first-page":"121837","DOI":"10.1016\/j.lfs.2023.121837","volume":"15","author":"P Su","year":"2023","unstructured":"Su, P., Chen, J. G. & Tang, D. H. Exercise against nonalcoholic fatty liver disease: Possible role and mechanism of lipophagy. Life Sci Aug. 15, 327:121837. https:\/\/doi.org\/10.1016\/j.lfs.2023.121837 (2023).","journal-title":"Life Sci Aug"},{"issue":"1","key":"45268_CR49","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","volume":"3","author":"M Ezpeleta","year":"2023","unstructured":"Ezpeleta, M. et al. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. Cell Metab Jan. 3 (1), 56\u201370e3. https:\/\/doi.org\/10.1016\/j.cmet.2022.12.001 (2023).","journal-title":"Cell Metab Jan"},{"issue":"1","key":"45268_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12993-020-00171-9","volume":"6","author":"DM Monir","year":"2020","unstructured":"Monir, D. M., Mahmoud, M. E., Ahmed, O. G., Rehan, I. F. & Abdelrahman, A. Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson\u2019s disease in rotenone-treated rats. Behav Brain Funct Nov. 6 (1), 9. https:\/\/doi.org\/10.1186\/s12993-020-00171-9 (2020).","journal-title":"Behav Brain Funct Nov"},{"key":"45268_CR51","doi-asserted-by":"publisher","first-page":"4165839","DOI":"10.1155\/2022\/4165839","volume":"2022","author":"L Li","year":"2022","unstructured":"Li, L., Liu, R., Niu, M. & Zhou, T. Effect of Aerobic Exercise on Liver Tissue in Rats with NAFLD. Biomed. Res. Int. 2022, 4165839. https:\/\/doi.org\/10.1155\/2022\/4165839 (2022).","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"45268_CR52","doi-asserted-by":"publisher","first-page":"2464223","DOI":"10.1080\/07853890.2025.2464223","volume":"57","author":"X Hao","year":"2025","unstructured":"Hao, X. et al. Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease. Ann Med Dec. 57 (1), 2464223. https:\/\/doi.org\/10.1080\/07853890.2025.2464223 (2025).","journal-title":"Ann Med Dec."},{"key":"45268_CR53","doi-asserted-by":"publisher","first-page":"1462145","DOI":"10.3389\/fmed.2025.1462145","volume":"12","author":"C Li","year":"2025","unstructured":"Li, C. et al. Ferroptosis in NAFLD: insights and the therapeutic potential of exercise. Front. Med. (Lausanne). 12, 1462145. https:\/\/doi.org\/10.3389\/fmed.2025.1462145 (2025).","journal-title":"Front. Med. (Lausanne)"},{"issue":"8","key":"45268_CR54","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/apt.15427","volume":"50","author":"Y Huber","year":"2019","unstructured":"Huber, Y. et al. Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program. Aliment Pharmacol. Ther Oct. 50 (8), 930\u2013939. https:\/\/doi.org\/10.1111\/apt.15427 (2019).","journal-title":"Aliment Pharmacol. Ther Oct."},{"issue":"6","key":"45268_CR55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s42255-021-00402-x","volume":"3","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming. Nat Metab Jun. 3 (6), 843\u2013858. https:\/\/doi.org\/10.1038\/s42255-021-00402-x (2021).","journal-title":"Nat Metab Jun"},{"key":"45268_CR56","doi-asserted-by":"publisher","first-page":"109414","DOI":"10.1016\/j.jnutbio.2023.109414","volume":"120","author":"P Cao","year":"2023","unstructured":"Cao, P. et al. Quercetin ameliorates nonalcoholic fatty liver disease (NAFLD) via the promotion of AMPK-mediated hepatic mitophagy. J Nutr. Biochem Oct. 120, 109414. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109414 (2023).","journal-title":"J Nutr. Biochem Oct."},{"key":"45268_CR57","doi-asserted-by":"publisher","first-page":"1508060","DOI":"10.3389\/fphar.2024.1508060","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. Apigenin as an emerging hepatoprotective agent: current status and future perspectives. Front. Pharmacol. 15, 1508060. https:\/\/doi.org\/10.3389\/fphar.2024.1508060 (2024).","journal-title":"Front. Pharmacol."},{"key":"45268_CR58","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.12659\/msm.907530","volume":"24","author":"H Fan","year":"2017","unstructured":"Fan, H. et al. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K\/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats. Med Sci. Monit Nov. 24, 23:5599\u20135612. https:\/\/doi.org\/10.12659\/msm.907530 (2017).","journal-title":"Med Sci. Monit Nov"},{"key":"45268_CR59","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bcp.2017.04.014","volume":"15","author":"X Feng","year":"2017","unstructured":"Feng, X. et al. Apigenin, a modulator of PPAR\u03b3, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. Biochem Pharmacol Jul. 15, 136:136\u2013149. https:\/\/doi.org\/10.1016\/j.bcp.2017.04.014 (2017).","journal-title":"Biochem Pharmacol Jul"},{"key":"45268_CR60","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.biopha.2018.06.108","volume":"105","author":"M Yang","year":"2018","unstructured":"Yang, M. et al. Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway. Biomed Pharmacother Sep. 105, 1283\u20131290. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.108 (2018).","journal-title":"Biomed Pharmacother Sep."},{"key":"45268_CR61","doi-asserted-by":"publisher","first-page":"111396","DOI":"10.1016\/j.foodres.2022.111396","volume":"157","author":"Z Chai","year":"2022","unstructured":"Chai, Z., Yan, Y., Zan, S., Meng, X. & Zhang, F. Probiotic-fermented blueberry pomace alleviates obesity and hyperlipidemia in high-fat diet C57BL\/6J mice. Food Res. Int Jul. 157, 111396. https:\/\/doi.org\/10.1016\/j.foodres.2022.111396 (2022).","journal-title":"Food Res. Int Jul"},{"key":"45268_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.focha.2026.101247","author":"D Gamage","year":"2026","unstructured":"Gamage, D., Kienesberger, P., Sinal, C. J. & Rupasinghe, H. P. V. Microencapsulated fermented wild blueberries attenuate diet-induced lipid dysmetabolism. Food Chem. Adv. https:\/\/doi.org\/10.1016\/j.focha.2026.101247 (2026). 03\/01\/ 2026;10:101247.","journal-title":"Food Chem. Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45268-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:05:36Z","timestamp":1778425536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45268-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45268"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45268-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"This research plan has been approved by the Ethics Committee of Harbin Sports University (Approval Number: 2025010). The current study is reported in accordance with the ARRIVE guidelines. Furthermore, the study followed the US National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals (NIH publication no. 85\u2009\u2212\u200923, revised 1996) and strictly adhered to the ethical guidelines and regulations stipulated by the Research Ethics Committee. All methods were performed in accordance with the ARRIVE guidelines and the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (8th edition).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"14469"}}